RECITAL 40

국가: 이스라엘

언어: 영어

출처: Ministry of Health

지금 구매하세요

환자 정보 전단 환자 정보 전단 (PIL)
06-08-2017
공공 평가 보고서 공공 평가 보고서 (PAR)
18-08-2016

유효 성분:

CITALOPRAM AS HYDROBROMIDE

제공처:

UNIPHARM LTD, ISRAEL

ATC 코드:

N06AB04

약제 형태:

TABLETS

구성:

CITALOPRAM AS HYDROBROMIDE 40 MG

관리 경로:

PER OS

처방전 유형:

Required

Manufactured by:

TRIMA ISRAEL PHARMACEUTICAL PRODUCTS MAABAROT LTD, ISRAEL

치료 그룹:

CITALOPRAM

치료 영역:

CITALOPRAM

치료 징후:

For the treatment of states of depression or panic disorder.

승인 날짜:

2011-07-31

환자 정보 전단

                                119278010
PATIENT PACKAGE INSERT IN ACCORDANCE WITH THE
PHARMACISTS’ REGULATIONS (PREPARATIONS) - 1986
This medicine is dispensed with a doctor’s prescription only
RECITAL 20 MG
RECITAL 40 MG
Tablets
Tablets
COMPOSITION:
Each RECITAL 20 tablet contains:
Citalopram (as HBr) 20 mg
Each RECITAL 40 tablet contains:
Citalopram (as HBr) 40 mg
Each RECITAL 20 tablet contains 76 mg lactose.
Each RECITAL 40 tablet contains 152 mg lactose.
For a list of the inactive ingredients, please see section 6.
READ THIS LEAFLET CAREFULLY IN ITS ENTIRETY BEFORE USING THE
MEDICINE. It is recommended to have a person close to you read this
leaflet. This leaflet contains concise information about the medicine.
If you have further questions, refer to the doctor or pharmacist.
This medicine has been prescribed to treat your ailment. Do not
pass it on to others. It may harm them even if it seems to you
that their medical condition is similar. This medicine is not usually
intended for use in children and adolescents below 18 years of age
(see “Special warnings regarding use of the medicine” section).
Antidepressants and anti-anxiety medicines increase the risk
of suicidal actions and thoughts in children, adolescents and
young adults up to the age of 25.
Following commencement of treatment with the medicine,
patients of all ages, as well as their relatives, should monitor
behavioral changes such as: worsening of depression, suicidal
thoughts, aggression etc.
Refer to the doctor immediately if such changes occur.
1. WHAT IS THE MEDICINE INTENDED FOR?
THERAPEUTIC ACTIVITY: For treatment of depression and anxiety
disorder.
RECITAL belongs to a group of antidepressants called selective
serotonin reuptake inhibitors (SSRI). These medicines increase
serotonin levels in the brain. Disturbances in the serotonin system
in the brain are considered an important factor in the development
of depression and related diseases.
THERAPEUTIC GROUP: selective serotonin reuptake inhibitors
(SSRI).
2. BEFORE USING THE MEDICINE DO NOT USE THE MEDICINE IF:
                                
                                전체 문서 읽기
                                
                            

다른 언어로 된 문서

환자 정보 전단 환자 정보 전단 히브리어 06-08-2017

이 제품과 관련된 검색 알림

문서 기록보기